Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cancers|September 5, 2020
Targeting Signaling Pathways in Inflammatory Breast CancerXiaoping Wang, Takashi Semba, Lan Thi Hanh Phi, et al.
Breast Cancer Research and Treatment|July 29, 2020
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancerSudpreeda Chainitikun, James P Long, Ruben Rodriguez-Bautista, et al.
Cancer Medicine|December 3, 2015
Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patientsToshiaki Iwase, Takafumi Sangai, Takeshi Nagashima, et al.
NPJ Breast Cancer|June 7, 2025
Inflammatory breast cancer, best practice in the community settingYoko Takahashi, Nithya Sridhar, Toshiaki Iwase, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[The Case of a Patient with Invasive Lobular Carcinoma with Solitary Metastasis in Pectoralis Major Muscle]Toshiaki Iwase, Takafumi Sangai, Masahiro Sakakibara, et al.
Cancers|March 13, 2025
Efficiency of Fulvestrant Monotherapy After CDK4/6 Inhibitor Exposure: Is This a Viable Choice?Nanae Ogata, Brian G Barnett, Nicholas J H Sharp, et al.
Cancers|June 2, 2021
Changes in Overall Survival over Time for Patients with de novo Metastatic Breast CancerToshiaki Iwase, Tushaar Vishal Shrimanker, Ruben Rodriguez-Bautista, et al.
Molecular and Clinical Oncology|March 31, 2017
An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancerToshiaki Iwase, Takafumi Sangai, Masahiro Sakakibara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Long-Term Outcome of Radiofrequency Ablation Therapy for Breast Cancer]Takeshi Nagashima, Masahiro Sakakibara, Takafumi Sangai, et al.
Pageof 4